What is the Biguanides Market Size and Growth Rate?
As per Data Bridge Market Research analysis, the biguanides market was valued at USD 8.68 billion in 2025 and is projected to reach USD 12.92 billion by 2033, growing at a CAGR of 5.10% from 2026 to 2033.
The market is experiencing steady growth driven by the increasing prevalence of type 2 diabetes, rising awareness of metabolic disorders, growing availability of generic biguanides, adoption of oral antidiabetic medications, and advancements in liver-targeted therapies.
𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -
The rising incidence of diabetes globally, particularly type 2 diabetes, combined with increasing demand for cost-effective and reliable treatment options, is supporting the adoption of biguanides. Metformin remains the most widely prescribed biguanide, while advancements in extended-release formulations, combination therapies, and expanded indications are contributing to continued market growth